top of page
FutureMeds_Clinical_Trials_Home_Hero_bg.jpg
FM Home Hero (1).png

Our Therapy Areas

Vaccines & Infectious diseases trials

Vaccines and infectious disease trials are designed to assess the safety, efficacy, and optimal use of vaccines and therapeutic interventions. Our investigators have a wealth of experience for conditions like COVID, RSV, Influenza and more.

Vaccine & Infectious Diseases Clinical Trials
COVID

COVID

COVID-19, caused by the novel coronavirus SARS-CoV-2, emerged as a global pandemic in early 2020. This infectious disease has had profound impacts on health, economies, and daily life worldwide. Our PIs have experience in the specific challenges of these trials to ensure high patient retention and quality data.

30 experienced FutureMeds Investigators

COVID Clinical Trials
Influenza Clinical Trials

Influenza

Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses. It can lead to mild to severe illness, and sometimes can result in hospitalization or death. Our site teams have the experts, experience and equipment to deliver high-quality Influenza trials.

25 experienced FutureMeds Investigators

Flu

RSV

Respiratory Syncytial Virus (RSV) is a common virus that primarily affects the respiratory tract. It is a major cause of respiratory illness in infants and young children, but it can also affect older adults and people with weakened immune systems. Our experts have experience in conducting RSV trials across Europe.

25 experienced FutureMeds Investigators

RSV Clinical Trials
RSV
Shingles Clinical Trials

Shingles

Shingles is a painful rash caused by the reactivation of the varicella-zoster virus (VZV), which also causes chickenpox. Once someone has had chickenpox, the virus remains dormant in the nerve cells and can reactivate years later to cause shingles. Our experienced teams have conducted multiple trials across Europe to give patients access to the latest innovative treatments.

4 experienced FutureMeds Investigators

Shingles

Pneummococcal

Pneumococcal disease can lead to a range of infections including pneumonia, meningitis, and bloodstream infections. This disease can affect people of all ages but is particularly serious in individuals with weakened immune systems. Our PIs have experience in the specific challenges of these trials to ensure high patient retention and quality data.

2 experienced FutureMeds Investigators

Pneum
Pertissus Clinical Trials

Pertussis

Pertussis, commonly known as whooping cough, is a highly contagious respiratory disease characterized by severe coughing fits that can lead to a “whooping” sound during inhalation. Our site teams have the experts, experience and equipment to deliver high performing Pertussis trials.

Access to consultants

Pert

Streptococcus

Streptococcus is a genus of gram-positive bacteria that can cause a wide range of infections in humans. Different species within the genus are responsible for various infections, ranging from mild to life-threatening. Our experts have experience in conducting Streptococcus trials across Europe.

Access to consultants

Stretococcus Clinical Trials
Strept
TB Clinical Trials

TB

Tuberculosis (TB) is a serious infectious and primarily affects the lungs but can also impact other parts of the body. TB is a global health issue and remains one of the top causes of death from infectious diseases worldwide. Our PIs have experience in the specific challenges of these trials to ensure high patient retention and quality data.

3 experienced FutureMeds Investigators

TB

Norovirus

Norovirus is a highly contagious virus that causes gastroenteritis, an inflammation of the stomach and intestines. It is known for its rapid spread, particularly in close-knit communities such as schools, nursing homes, and cruise ships. Our site teams have the experts, experience and equipment to deliver high-quality Norovirus Trials.

Access to consultants

Norovirus Clinical Trials
Norovirus
“Vaccine research is the cornerstone of global health, offering the promise of a world free from preventable diseases. FutureMeds principal investigators like me are driven by an unwavering commitment to progress, knowing that every discovery brings us one step closer to safeguarding future generations.”
Principal Investigator

Dr Peter Hahn

Principal Investigator

bottom of page